SLC2A1 and diabetes mellitus: To investigate if increased glucose flux into myeloid cells per se could mimic the effects of diabetes in non-diabetic mice, we overexpressed GLUT1 under control of the CD68 promoter in hematopoietic cells, which results in expression primarily in myeloid cells (136).